Adherence to and determinants of guideline-recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice.

Kelsey S Lau-MinYimei LiJennifer R EadsXiaoliang WangNeal J MeropolRonac MamtaniKelly D Getz

Published in: Cancer (2021)

In patients with advanced GEA, guideline-recommended HER2 testing and anti-HER2 therapy remain underused. Uptake may improve with universal HER2 testing regardless of stage.

Keyphrases

primary care
healthcare
squamous cell carcinoma
clinical practice
stem cells